These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9770195)

  • 21. Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.
    Nicolau DP; Wu AH; Finocchiaro S; Udeh E; Chow MS; Quintiliani R; Nightingale CH
    Ther Drug Monit; 1996 Jun; 18(3):263-6. PubMed ID: 8738765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.
    Nezic L; Derungs A; Bruggisser M; Tschudin-Sutter S; Krähenbühl S; Haschke M
    Eur J Clin Pharmacol; 2014 Jul; 70(7):829-37. PubMed ID: 24756148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing dose prediction software used to manage gentamicin dosing.
    Wong C; Kumar SS; Graham GG; Begg EJ; Chin PK; Brett J; Ray JE; Marriott DJ; Williams KM; Day RO
    Intern Med J; 2013 May; 43(5):519-25. PubMed ID: 23279297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing 3 methods of monitoring gentamicin concentrations in patients with febrile neutropenia.
    Avent ML; Teoh J; Lees J; Eckert KA; Kirkpatrick CM
    Ther Drug Monit; 2011 Oct; 33(5):592-601. PubMed ID: 21912332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum aminoglycoside monitoring by enzyme immunoassay, biological, and fluorescence immunoassay procedures.
    Buchanan AG; Witwicki E; Albritton WL
    Am J Med Technol; 1983 Jun; 49(6):437-41. PubMed ID: 6349357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoglycoside levels in critically ill surgical patients: the implications of physiologic criteria of sepsis.
    Cornwell EE; Belzberg H; Berne TV; Kern JW; Henriques G; Asensio JA; Demetriades D
    South Med J; 1997 Jan; 90(1):33-6. PubMed ID: 9003820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
    Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
    Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.
    Massey KL; Hendeles L; Neims A
    J Pediatr; 1986 Nov; 109(5):897-901. PubMed ID: 3095524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration.
    Dupuis LL; Sung L; Taylor T; Abdolell M; Allen U; Doyle J; Taddio A
    Pharmacotherapy; 2004 May; 24(5):564-73. PubMed ID: 15162890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and implementation of simplified aminoglycoside empiric dosing guidelines.
    Reesor Nimmo C; Mamdani F; Baker A; Jewesson P
    Pharmacotherapy; 1993; 13(4):408-14. PubMed ID: 8361871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.
    Leong CL; Buising K; Richards M; Robertson M; Street A
    Intern Med J; 2006 Jan; 36(1):37-42. PubMed ID: 16409311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methods.
    Franson TR; Quebbeman EJ; Whipple J; Thomson R; Bubrick J; Rosenberger SL; Ausman RK
    Crit Care Med; 1988 Sep; 16(9):840-3. PubMed ID: 3402229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
    Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
    Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic monitoring as an aid in rationalizing aminoglycoside dosage techniques in the neonate.
    Spruyt LL; Kirsten GF; Parkin DP; Müller GJ; Kriegler A
    S Afr Med J; 1987 Oct; 72(7):463-5. PubMed ID: 3660149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.
    Mayhew JW; Gorbach SL
    Antimicrob Agents Chemother; 1978 Dec; 14(6):851-55. PubMed ID: 369455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.
    Vella D; Walker SA; Walker SE; Daneman N; Simor A
    J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.